References

  1. ACANYA® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5% Prescribing Information. February, 2014.
  2. Data on File, Valeant Pharmaceuticals.
  3. Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol. 2008;59:792-800.
  4. Fu LW and Vender RB. Newer approaches in topical combination therapy for acne. Skin Therapy Letter. 2011;16(9):1-8.
  5. American Academy of Dermatology. Who gets acne and causes. Available at: http://www.aad.org/dermatology-a-to-z/diseases-and-treatments/a---d/acne/who-gets-causes. Accessed Sept 5, 2014.
  6. Russell JJ. Topical therapy for acne. Am Fam Physician 2000;61(2):357-365.
  7. Cook-Bolden F. Clindamycin phosphate 1.2% and benzoyl peroxide 2.5%: a new, once-daily, fixed combination treatment for moderate to severe acne. Cosmet Dermatol 20009;22(6):319-322.
  8. ACZONE® (dapsone) Gel, 5% Prescribing Information. March, 2013.
  9. DUAC (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/5% Prescribing Information. December, 2013.
  10. EPIDUO® (adalapene and benzoyl peroxide) Gel, 0.1%/2.5% Prescribing Information. January, 2013.